International journal of obstetric anesthesia
-
The effectiveness of postoperative pain relief and the frequency of side effects with three different doses of epidural diamorphine (2.0, 3.5 and 5 mg) was investigated. The study was carried out double-blind in 30 women undergoing awake elective caesarean section. Postoperative pain intensity was measured on a linear analogue scale. ⋯ Three patients in the 2 mg group failed to achieve scores of zero but were comfortable. No nausea or vomiting was seen but the incidence of itching was 0, 30% and 80% in the 2.0, 3.5 and 5 mg groups respectively. We conclude that epidural diamorphine 2 mg is adequate for relief of post-caesarean pain and higher doses may increase the incidence of unwanted side-effects.
-
Int J Obstet Anesth · Jan 1992
The effectiveness of low dose droperidol in controlling nausea and vomiting during epidural anesthesia for cesarean section.
The antiemetic efficacy of 0.5 mg of droperidol was evaluated in 128 term parturients undergoing elective and non-urgent cesarean section with epidural anesthesia. Following delivery, parturients received intravenously either 0.5 mg of droperidol or normal saline in a double-blinded fashion. Droperidol decreased nausea after delivery from 41 to 13% (P=0.001). ⋯ Analysis of the data using logistic regression analysis showed that increasing age (P = 0.002), hypotension after delivery (P = 0.040), and vomiting prior to delivery (P = 0.017) were associated with increased nausea after delivery. No extrapyramidal symptoms or significant changes in pulse rate or blood pressure were associated with droperidol administration. We conclude that 0.5 mg of intravenous droperidol decreases nausea in term parturients undergoing non-urgent cesarean section with epidural anesthesia without producing unwanted side-effects.
-
Int J Obstet Anesth · Jan 1992
Epidural insertion: how far should the epidural needle be inserted before testing for loss of resistance?
The aim of this study was to determine the depth to which an epidural needle can safely be inserted before testing for loss of resistance. This ensures that the epidural needle is advanced far enough to encounter ligament thus avoiding the confusion that can occur when testing for loss of resistance whilst still in subcutaneous tissues. A survey of the distance between the skin and the epidural space in 400 obstetric patients was performed. ⋯ Dividing the patient's pregnant weight by 25 will give this distance in centimetres. Seventy six paramedian approaches were performed and a less good correlation was found between the depth of the space and the woman's weight. There was no correlation with height or foot size.